Bilal H. Lashari, Yazhini Vallatharasu, Lakshmi Kolandra, Mohsin Hamid, & Dipesh Uprety. (2018). Rovalpituzumab Tesirine: A Novel DLL3-Targeting Antibody-Drug Conjugate. Adis, Springer Healthcare.
Style de citation Chicago (17e éd.)Bilal H. Lashari, Yazhini Vallatharasu, Lakshmi Kolandra, Mohsin Hamid, et Dipesh Uprety. Rovalpituzumab Tesirine: A Novel DLL3-Targeting Antibody-Drug Conjugate. Adis, Springer Healthcare, 2018.
Style de citation MLA (9e éd.)Bilal H. Lashari, et al. Rovalpituzumab Tesirine: A Novel DLL3-Targeting Antibody-Drug Conjugate. Adis, Springer Healthcare, 2018.
Attention : ces citations peuvent ne pas être correctes à 100%.